ALTIVIA Acquires Axiall's Specialty Phosgene Derivatives Business

February 26, 2015

ALTIVIA has signed a definitive agreement to acquire the Specialty Phosgene Derivatives business and related assets from Axiall Corporation, including the La Porte, Texas chemical production facility. The transaction transfers roughly 120 facility employees to ALTIVIA and is intended to expand ALTIVIA's manufacturing capabilities and global competitiveness in specialty phosgene-derived products used in agricultural, pharmaceutical and industrial applications.

Buyers
ALTIVIA
Targets
Axiall's Specialty Phosgene Derivatives business
Sellers
Axiall Corporation
Industry
Manufacturing
Location
Texas, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.